Genomictree Inc.

Genomictree Inc. is a biomarker-based molecular diagnostics company that develops and commercializes molecular diagnostic products for detecting cancer and various infectious diseases. Its offerings include EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L, for detecting epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B, for detecting genetic and epigenetic markers associated with bladder cancer in hematuria patients. The company also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. Founded in 2000, Genomictree is headquartered in Daejeon, South Korea.